What's in a name for Degussa's NCN unit?
Fine chemicals firm Degussa has decided to spin off its NCN business in Bavaria into a new legal entity known as AlzChem Trostberg, hoping a new name will lead to new opportunities.
Archives for September 27, 2006
Sanofi breaks ground in cell culture-based vaccine production
With the first clinical trial of its cell culture-based seasonal influenza vaccine commencing in the US, Sanofi Pasteur has demonstrated the production scale potential of a cell line in a successful bioreactor run of 20,000L.
Software companies join e-pedigree forces
Software firm Ross Systems and supply chain company SupplyScape have announced a partnership to provide a software solution that allows pharmaceutical manufacturers to track their product through the supply chain, meeting regulatory and trading...
US contract manufacturer unveils $17.5m expansion
US contract pharmaceutical manufacturer Metrics has announced a $17.5m (€13.7m) investment to double the size of its drug testing and manufacturing plant over the next three years.
DNA hydrogels could be used in drug delivery
The use of synthetic DNA formed into crosses can produce biodegradable and inexpensive hydrogels that have applications in the controlled release of drugs, new research indicates.
Self-regulation required while India's clinical regulatory body matures
As India's clinical regulatory authorities find their feet, the clinical trials industry must practice self-regulation to maintain global standards.
Tandem Labs acquires PharmaKD to expand its services
Targeting the market for drug metabolite identification and biomarker discovery, Tandem Labs has acquired PharmaKD, a Massachussets-based division of Linden Technologies.